Comparison between Akums Drugs IPO and Ceigall India IPO.
Akums Drugs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Ceigall India IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Akums Drugs IPO is up to ₹1,856.74 Cr whereas the issue size of the Ceigall India IPO is up to ₹1,252.66 Cr. The final issue price of Akums Drugs IPO is ₹679.00 per share and of Ceigall India IPO is ₹401.00 per share.
| Akums Drugs IPO | Ceigall India IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹5 per share |
| Issue Price (Lower) | ₹646.00 per share | ₹380.00 per share |
| Issue Price (Upper) | ₹679.00 per share | ₹401.00 per share |
| Issue Price (Final) | ₹679.00 per share | ₹401.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹64.00 per share | ₹38.00 per share |
| Market Lot Size | 22 shares | 37 shares |
| Fresh Issue Size | 1,00,37,708 shares | 1,70,68,861 shares |
| Fresh Issue Size (Amount) | up to ₹680.99 Cr | up to ₹684.35 Cr |
| OFS Issue Size | 1,73,30,435 shares | 1,41,74,840 shares |
| OFS Issue Size (Amount) | up to ₹1,175.75 Cr | up to ₹568.32 Cr |
| Issue Size Total | 2,73,68,143 shares | 3,12,43,701 shares |
| Issue Size Total (Amount) | up to ₹1,856.74 Cr | up to ₹1,252.66 Cr |
Akums Drugs IPO opens on Jul 30, 2024, while Ceigall India IPO opens on Aug 01, 2024. The closing date of Akums Drugs IPO and Ceigall India IPO is Aug 01, 2024, and Aug 05, 2024, respectively.
| Akums Drugs IPO | Ceigall India IPO | |
|---|---|---|
| Anchor Bid Date | Jul 29, 2024 | Jul 31, 2024 |
| Issue Open | Jul 30, 2024 | Aug 01, 2024 |
| Issue Close | Aug 01, 2024 | Aug 05, 2024 |
| Basis Of Allotment (Tentative) | Aug 02, 2024 | Aug 06, 2024 |
| Initiation of Refunds (Tentative) | Aug 05, 2024 | Aug 07, 2024 |
| Credit of Share (Tentative) | Aug 05, 2024 | Aug 07, 2024 |
| Listing date (Tentative) | Aug 06, 2024 | Aug 08, 2024 |
| Anchor Lockin End date 1 | Sep 01, 2024 | Sep 04, 2024 |
| Anchor Lockin End date 2 | Oct 31, 2024 | Nov 03, 2024 |
Akums Drugs IPO P/E ratio is , as compared to Ceigall India IPO P/E ratio of 20.67.
| Akums Drugs IPO | Ceigall India IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 82.48 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 75.29 | 82.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 20.67 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹6985.41 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 0.11% | 33.57% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 3.37% | 31.98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.69 | 1.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹19.40 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -0.57 | 33.57% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Akums Drugs IPO Retail Individual Investors (RII) are offered 27,12,424 shares while in Ceigall India IPO retail investors are offered 27,12,424 shares. Qualified Institutional Buyers (QIB) are offered 81,37,276 shares in Akums Drugs IPO and 62,37,721 shares in Ceigall India IPO.
| Akums Drugs IPO | Ceigall India IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,22,05,912 shares | 93,56,581 shares |
| Market Maker Reservation | ||
| QIB | 81,37,276 shares | 62,37,721 shares |
| NII | 40,68,637 shares | 46,78,291 shares |
| RII | 27,12,424 shares | 1,09,16,012 shares |
| Employee | 2,43,902 shares | 55,096 shares |
| Others | ||
| Total | 2,73,68,151 shares | 3,12,43,701 shares |
Akums Drugs IPO subscribed 63.44x in total, whereas Ceigall India IPO subscribed 14.01x.
| Akums Drugs IPO | Ceigall India IPO | |
|---|---|---|
| QIB (times) | 90.09x | 31.26x |
| NII (times) | 42.10x | 14.83x |
| Big NII (times) | 47.43x | 16.28x |
| Small NII (times) | 31.45x | 11.92x |
| RII (times) | 20.80x | 3.82x |
| Employee (times) | 4.14x | 11.84x |
| Other (times) | ||
| Total (times) | 63.44x | 14.01x |
